These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2296871)

  • 21. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent implantation reduces restenosis in patients with suboptimal results following coronary angioplasty.
    Knight CJ; Curzen NP; Groves PH; Patel DJ; Goodall AH; Wright C; Clarke D; Oldershaw PJ; Fox KM
    Eur Heart J; 1999 Dec; 20(24):1783-90. PubMed ID: 10581136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restenosis and its determinants in first and repeat coronary angioplasty.
    Rapold HJ; David PR; Guiteras Val P; Mata AL; Crean PA; Bourassa MG
    Eur Heart J; 1987 Jun; 8(6):575-86. PubMed ID: 2957201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina.
    Foley JB; Chisholm RJ; Common AA; Langer A; Armstrong PW
    Am Heart J; 1992 Nov; 124(5):1174-80. PubMed ID: 1442483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis.
    Bauters C; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Circulation; 1995 Nov; 92(9):2473-9. PubMed ID: 7586347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early luminal deterioration following successful percutaneous transluminal coronary angioplasty. Frequency, prediction and clinical implications.
    Preisack MB; Athanasiadis A; Voelker W; Karsch KR
    Eur Heart J; 1994 Jun; 15(6):739-46. PubMed ID: 8088261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalization of coronary vasomotion after percutaneous transluminal coronary angioplasty?
    Suter TM; Buechi M; Hess OM; Haemmerli-Saner C; Gaglione A; Krayenbuehl HP
    Circulation; 1992 Jan; 85(1):86-92. PubMed ID: 1728488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study).
    Dietz U; Rupprecht HJ; Ekinci O; Dill T; Erbel R; Kuck KH; Abdollahnia R; Rippin G; Meyer J; Hamm C
    Catheter Cardiovasc Interv; 2001 Jul; 53(3):359-67. PubMed ID: 11458414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregability and occurrence of restenosis following coronary angioplasty.
    Goel PK; Shahi M; Agarwal AK; Srivastava S; Seth PK
    Int J Cardiol; 1997 Aug; 60(3):227-31. PubMed ID: 9261632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of restenosis at one previously dilated coronary site on the probability of restenosis at another previously dilated coronary site.
    Weintraub WS; Brown CL; Liberman HA; Morris DC; Douglas JS; King SB
    Am J Cardiol; 1993 Nov; 72(15):1107-13. PubMed ID: 8237797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty.
    Le Feuvre C; Bonan R; Lespérance J; Gosselin G; Joyal M; Crépeau J
    Am J Cardiol; 1994 May; 73(12):840-4. PubMed ID: 8184804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphologic characteristics of restenotic lesions following coronary interventions: balloon angioplasty versus directional atherectomy: can we speculate about the mechanism of restenosis from morphologic analysis?
    Moreu J; Silver MT; Palacios IF; Jang IK
    Cathet Cardiovasc Diagn; 1995 Oct; 36(2):103-9; discussion 110-1. PubMed ID: 8829829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of coronary artery disease after percutaneous transluminal coronary angioplasty.
    Hwang MH; Sihdu P; Pacold I; Johnson S; Scanlon PJ; Loeb HS
    Am Heart J; 1988 Feb; 115(2):297-301. PubMed ID: 2963511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.
    Holmes DR; Vlietstra RE; Smith HC; Vetrovec GW; Kent KM; Cowley MJ; Faxon DP; Gruentzig AR; Kelsey SF; Detre KM
    Am J Cardiol; 1984 Jun; 53(12):77C-81C. PubMed ID: 6233894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic follow-up after successful percutaneous coronary angioplasty for chronic total coronary occlusion: experience in 110 consecutive patients.
    Ishizaka N; Issiki T; Saeki F; Ishizaka Y; Ikari Y; Abe J; Soumitsu Y; Hashimoto H; Masaki K; Yamaguchi T
    Am Heart J; 1994 Jan; 127(1):8-12. PubMed ID: 8273760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical prognosis of moderate restenosis after percutaneous transluminal coronary angioplasty].
    Fukuzawa S; Ozawa S; Katagiri M; Watanabe H
    J Cardiol; 1995 Feb; 25(2):63-8. PubMed ID: 7897608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.